Stabilizers containing recombinant human serum albumin for live virus vaccines
US6210683A · kind A · utility
19Cited by
13References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 1998 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Aug 26, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions are provided for improving the stability of live virus vaccines containing, e.g., live varicella zoster, measles, mumps, and rubella viruses. Such improved stabilizers are aqueous solutions containing recombinant human serum albumin (rHA) as a component at from 1-100 g/l. Live virus vaccines as well as methods of preparing live virus vaccines containing the stabilizers are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.